Management of Mild Hyperammonemia

Diagnostic Considerations

The American Academy of Pediatrics and other medical societies suggest that normal ammonia ranges vary by age, with upper limits reaching 110 μmol/L (154 μg/dL) in the first week of life 1
At an ammonia level of 60 μmol/L, the patient is at the upper limit of normal or mildly elevated, requiring investigation but not emergency treatment 1
The key determinant of treatment is clinical status, not just the ammonia number, with assessment for encephalopathy, altered consciousness, vomiting, or seizures 1, 3

The European Society for Pediatric Gastroenterology, Hepatology and Nutrition recommends temporarily stopping protein intake to reduce nitrogen load while investigations are underway 1, 4
Provide adequate calories (≥100 kcal/kg daily) as intravenous glucose and lipids to prevent catabolism, which would drive ammonia production higher 1, 4
Maintain glucose infusion rate of 8-10 mg/kg/min and add IV lipids starting at 0.5 g/kg/day, up to 3 g/kg/day for caloric support 1, 4
Reintroduce protein within 48 hours (starting at 0.25 g/kg/day, advancing to 1.5 g/kg/day) once ammonia stabilizes at 80-100 μmol/L to avoid catabolism 1, 4, 5

The American College of Medical Genetics and Genomics suggests that nitrogen-scavenging agents (sodium benzoate, sodium phenylacetate) are generally indicated at ammonia levels >150 μmol/L (255 μg/dL) 1, 2, 5
Hemodialysis or CKRT is indicated when ammonia exceeds 300-400 μmol/L (513-681 μg/dL) despite medical therapy, or with moderate to severe encephalopathy 1, 2, 3
Assess neurological status regularly for signs of encephalopathy (lethargy, confusion, altered consciousness) and monitor for vomiting, seizures, or respiratory pattern changes 1, 2, 5

The Society for Inherited Metabolic Disorders states that duration of hyperammonemic coma (not ammonia level per se) is the most important prognostic factor for neurological damage 1, 2
At 60 μmol/L without encephalopathy, risk of permanent neurological damage is minimal with appropriate supportive care 1
Adverse outcomes are associated with coma lasting >3 days or peak ammonia >1,000 μmol/L (1,703 μg/dL) 1, 2